Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_assertion type Assertion NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_head.
- NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_assertion description "[Patients were genotypically classified into 6 groups: 23 normal (mean sTfR+/-SD mg/l, 0.94+/-0.22), 14 alpha(+)-thalassemia heterozygotes (1.06+/-0.45), 21 alpha(0)-thalassemia heterozygotes (1.31+/-0.35), 30 HbE heterozygotes (1.11+/-0.26), 13 HbE heterozygotes with alpha(+)-thalassemia heterozygotes (1.09+/-0.32), and 12 HbE heterozygotes with alpha(0)-thalassemia heterozygotes (1.16+/-0.27).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_provenance.
- NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_assertion evidence source_evidence_literature NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_provenance.
- NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_assertion SIO_000772 19361457 NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_provenance.
- NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_assertion wasDerivedFrom befree-20140225 NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_provenance.
- NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_assertion wasGeneratedBy ECO_0000203 NP662207.RA3IYdw-pU4kParbJ22xxFi4LCDodgbcQcLFcPrR1RIYc130_provenance.